Non-diabetic nodular glomerulosclerosis secondary to multiple myeloma: Case report
DOI:
https://doi.org/10.33448/rsd-v13i7.46300Keywords:
Renal failure; Nodular glomerulosclerosis; Multiple myeloma.Abstract
Non-diabetic nodular glomerulosclerosis or idiopathic glomerulosclerosis is an uncommon condition with a poor prognosis. The study reports the case of a 54-year-old male patient, J.F.D.S., with no previous comorbidities, a former small-scale alcoholic, diagnosed with hypertension and asthma four months previously. During follow-up, he presented with hypertension that was difficult to control, and due to a complaint of asthenia, he underwent laboratory tests which were compatible with a progressive worsening of renal function. The renal biopsy showed non-diabetic nodular glomerulosclerosis. This case report portrays a rare disease with a poor prognosis and no established treatment, so studies are needed to better manage this condition. The objective of the study is to present and discuss a clinical case of non-diabetic nodular glomerulosclerosis secondary to multiple myeloma, describing the diagnostic methods used and the patient's evolution.
References
Alcatrão, M. J., Neves, C., Gaspar, A., Bravo, A., Margarido, E., & Estrada, H. (2016). Mieloma múltiplo e amiloidose AL. Medicina Interna, 23(1), 28-31.
Antunes, J. L. F. (2016). A dictionary in the dynamics of epidemiology. Revista Brasileira de Epidemiologia, 19, 219-223.
Bergantim, R., Santos, J., Afonso, C., Bernardo, P., Coelho, H., & Geraldes, C. (2023). Recomendações do Grupo Português do Mieloma Múltiplo para Tratamento do Mieloma Múltiplo. Acta Médica Portuguesa, 36(7-8), 517-526.doi: 10.20344/amp.19037.
Buti, E., Dervishi, E., Ghiandai, G., Mjeshtri, A., Paudice, N., Terreni, A., & Bergesio, F. (2014). La rimozione delle catene leggere libere in corso di aki da mieloma multiplo: ruolo delle membrane ad elevato cut-off. G Ital Nefrol, 31(6), 1724-5590.
D’Agostino, M., Terragna, C., & van Duin, M. (2023). Risk factors in multiple myeloma identified before and during treatment: are we ready to personalize treatment?. Frontiers in Oncology, 13, 124-138. .10.3389/fonc.2023.1247808.
Eadon, M. T., Lampe, S., Baig, M. M., Collins, K. S., Melo Ferreira, R., Mang, H., & Kidney Precision Medicine Project. (2022). Clinical, histopathologic and molecular features of idiopathic and diabetic nodular mesangial sclerosis in humans. Nephrology Dialysis Transplantation, 37(1), 72-84. http://dx.doi.org/10.1093/n:dt/gfaa331.
Fermand, J. P., Bridoux, F., Dispenzieri, A., Jaccard, A., Kyle, R. A., Leung, N., & Merlini, G. (2018). Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications. Blood, The Journal of the American Society of Hematology, 132(14), 1478-1485.. http://dx.doi.org/10.1182/blood-2018-04-839480.
Gharwan, H. & Truica, C.I. (2012).. Quimioterapia à base de bortezomibe para doença de deposição de cadeias leves apresentando-se como insuficiência renal aguda. Oncologia Médica. 29(77), 1197-1201.
Gillmore, J. D., Wechalekar, A., Bird, J., Cavenagh, J., Hawkins, S., Kazmi, M., & Pratt, G. (2015). Guidelines on the diagnosis and investigation of AL amyloidosis. British journal of haematology, 168(2).. http://dx.doi.org/10.1111/bjh.13156
Hutchison, C. A., Heyne, N., Airia, P., Schindler, R., Zickler, D., Cook, M., & Grima, D. (2012). Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis. Nephrology Dialysis Transplantation, 27(10), 3823-3828. 10.1093/ndt/gfr773.
Jensen, R., & Larsen, V. S. (1990). Nodular mesangial glomerulosclerosis in patients without manifest diabetes mellitus. International Urology and Nephrology, 22, 95-103.http://dx.doi.org/10.1007/bf02550442.
Kyle, R. A., Durie, B. G. M., Rajkumar, S. V., Landgren, O., Bladé, J., Merlini, G., & Boccadoro, M. (2010). Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia, 24(6), 1121-1127.https://doi.org/10.1038/leu.2010.60
Li, W., & Verani, R. R. (2008). Idiopathic nodular glomerulosclerosis: a clinicopathologic study of 15 cases. Human pathology, 39(12), 1771-1776. http://dx.doi.org/10.1016/j.humpath.2008.05.004.
Lin, Z. S., Zhang, X., Li, D. Y., Yu, X. J., Qin, A. B., Dong, Y., ... & Zhao, M. H. (2022). Clinicopathological features and outcomes of coexistent light chain cast nephropathy and light chain deposition disease in patients with newly diagnosed multiple myeloma. Journal of Clinical Pathology, 75(10), 668-674. http://dx.doi.org/10.1136/jclinpath-2021-207449.
Long, T. E., Indridason, O. S., Palsson, R., Rognvaldsson, S., Love, T. J., Thorsteinsdottir, S., & Kristinsson, S. Y. (2022). Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study. Blood Cancer Journal, 12(9), 133. 10.1038/s41408-022-00732-3.
Maiolino, A., & Magalhães, R. J. (2007). Mieloma múltiplo e insuficiência renal. Revista Brasileira de Hematologia e Hemoterapia, 29, 86-91. http://dx.doi.org/10.1590/s1516-84842007000100016.
Mangiacavalli, S., Cartia, C. S., Galli, M., Pezzatti, S., Belotti, A., Fazio, F., & Petrucci, M. T. (2023). Lenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis. Haematologica, 108(3), 833.10.3324/haematol.2022.281342.
Markowitz, G. S., Lin, J., Valeri, A. M., Avila, C., Nasr, S. H., & D'Agati, V. D. (2002). Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking. Human pathology, 33(8), 826-835. http://dx.doi.org/10.1053/hupa.2002.126189.
Nasr, S. H., Valeri, A. M., Sethi, S., Fidler, M. E., Cornell, L. D., Gertz, M. A., & Leung, N. (2012). Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies. American Journal of Kidney Diseases, 59(6), 786-794. http://dx.doi.org/10.1053/j.ajkd.2011.12.028
Pereira, A. S., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica.
Riley, D., Barber, M., Kienle, G., Aronson, J., von Schoen-Angerer, T., Tugwell, P., & Gagnier, J. (2017). Explicações e elaborações do CARE 2013: diretrizes de relatórios para relatos de casos. Journal of Clinical Epidemiology , 89.
Rajkumar, S. V., Dimopoulos, M. A., Palumbo, A., Blade, J., Merlini, G., Mateos, M. V., Kumar, S., Hillengass, J., Kastritis, E., Richardson, P., Landgren, O., Paiva, B., Dispenzieri, A., Weiss, B., LeLeu, X., Zweegman, S., Lonial, S., Rosinol, L., Zamagni, E., Jagannath, S., & Miguel, J. F. (2014). International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. The Lancet. Oncology, 15(12), e538–e548. https://doi.org/10.1016/S1470-2045(14)70442-5.
Souto Filho, J. T. D., Monteiro, J. M. G., & Andrade, I. B. D. (2016). Tratamento da doença de depósito de cadeia leve idiopática: remissão completa com bortezomib e dexametasona. Brazilian Journal of Nephrology, 38, 450-454.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Lívia Maria Alves de Souza; Fernando Antônio Galvão Gondim Filho; Tiago Moura de Freitas; Larissa Nascimento Agra de Santana
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
